RNA, 5S ribosomal pseudogene 30 (RNA5SP30)

RNA, 5S ribosomal pseudogene 30 (RNA5SP30) is a processed pseudogene in the human genome, derived from the 5S ribosomal RNA sequence[1]. Processed pseudogenes generally arise via retrotransposition of RNA transcripts and lack introns or independent promoters, so they are usually non-functional and not translated into protein[3][7][8][9]. While the majority of pseudogenes are transcriptionally silent, some may be transcribed and exert regulatory effects at the RNA level, for example by acting as antisense transcripts or miRNA sponges, indirectly influencing the expression of other genes[3][4][5][8]. There is no evidence that RNA5SP30 has any protein product, direct biological function, or clinical relevance as a drug target. Pseudogenes as a class can participate in gene regulation in cancer or other diseases, but specific evidence for RNA5SP30 involvement in such processes is lacking[1][5][8].\n\nThere is nothing to suggest RNA5SP30 is misspelled, but it is not a conventional molecular target, nor is it known to be pharmacologically actionable. Its inclusion as a "target" is likely a misclassification, and information about drugs, mechanisms, biomarkers, and safety do not apply.

Other names

RNA5SP30RN5S30RNA, 5S ribosomal 30